Literature DB >> 14511117

Pro-apoptotic protein kinase C delta is associated with intranuclear inclusions in a transgenic model of Huntington's disease.

Evgeny A Zemskov1, Nihar R Jana, Masaru Kurosawa, Haruko Miyazaki, Naoaki Sakamoto, Munenori Nekooki, Nobuyuki Nukina.   

Abstract

In order to investigate any effect of truncated mutant huntingtin (tNhtt) aggregation on protein kinase C (PKC) signaling in Huntington's disease (HD), we studied a possible association of PKC isoforms with the aggregates using cellular and transgenic models of HD. In this report we describe an association of mutant tNhtt with at least three PKC isoforms (alpha, delta, zeta), as revealed by co-immunoprecipitation assays and immunocytochemistry in a cellular model of HD (Neuro2a cells expressing tNhtt-150Q-EGFP), as well as a specific association of PKC delta with intranuclear aggregates in a transgenic model (R6/2 mice). Immunoblot analysis of isolated nuclear fractions shows an elevation of nuclear PKC delta in transgenic brain tissue. The observed elevation has a strong similarity with the apoptotic translocation of PKC delta detected in experiments with the mouse neuroblastoma Neuro2a cells. Using a Neuro2a cell line expressing tNhtt with the nuclear localization signal, we demonstrate the association of PKC delta with intranuclear aggregates and present evidence that accumulation of PKC delta in cell nuclei does not depend on mutant htt nuclear translocation. Our results suggest that the association of PKC delta with intranuclear htt-aggregates may affect its apoptotic function in a transgenic model of HD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511117     DOI: 10.1046/j.1471-4159.2003.02002.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.

Authors:  Elizabeth B Rex; Michele L Rankin; Yu Yang; Quansheng Lu; Charles R Gerfen; Pedro A Jose; David R Sibley
Journal:  Mol Pharmacol       Date:  2010-04-15       Impact factor: 4.436

2.  Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein.

Authors:  Peter O Bauer; Anand Goswami; Hon Kit Wong; Misako Okuno; Masaru Kurosawa; Mizuki Yamada; Haruko Miyazaki; Gen Matsumoto; Yoshihiro Kino; Yoshitaka Nagai; Nobuyuki Nukina
Journal:  Nat Biotechnol       Date:  2010-02-28       Impact factor: 54.908

3.  Rottlerin inhibits (Na+, K+)-ATPase activity in brain tissue and alters D-aspartate dependent redistribution of glutamate transporter GLAST in cultured astrocytes.

Authors:  Khoa T D Nguyen; Jae-Won Shin; Caroline Rae; Ellas K Nanitsos; Gabriela B Acosta; David V Pow; Vlado Buljan; Maxwell R Bennett; Paul L Else; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2009-06-03       Impact factor: 3.996

4.  Inhibition of Rho kinases enhances the degradation of mutant huntingtin.

Authors:  Peter O Bauer; Hon Kit Wong; Fumitaka Oyama; Anand Goswami; Misako Okuno; Yoshihiro Kino; Haruko Miyazaki; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

5.  Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.

Authors:  Laura Rué; Rafael Alcalá-Vida; Graciela López-Soop; Jordi Creus-Muncunill; Jordi Alberch; Esther Pérez-Navarro
Journal:  Neuromolecular Med       Date:  2013-07-30       Impact factor: 3.843

Review 6.  Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.

Authors:  Andreas Wyttenbach
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Emanuela Paldino; Vincenza D'Angelo; Daunia Laurenti; Cecilia Angeloni; Giuseppe Sancesario; Francesca R Fusco
Journal:  Cells       Date:  2020-10-13       Impact factor: 6.600

8.  ROCK-phosphorylated vimentin modifies mutant huntingtin aggregation via sequestration of IRBIT.

Authors:  Peter O Bauer; Roman Hudec; Anand Goswami; Masaru Kurosawa; Gen Matsumoto; Katsuhiko Mikoshiba; Nobuyuki Nukina
Journal:  Mol Neurodegener       Date:  2012-08-28       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.